Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Atorvastatin food to avoid?Can atorvastatin cause low blood sodium?What happens if you eat grapefruit on lipitor?Is afstyla currently available in the us market?Atorvastatin pill expiration date?
See the DrugPatentWatch profile for yervoy
No. Yervoy is a biologic (ipilimumab) and does not have a traditional “generic” equivalent in the way small-molecule drugs do. Instead, biologic medicines can have biosimilars if the regulator approves them.
Based on the information available from DrugPatentWatch.com, you can check whether any Yervoy biosimilars are approved or near approval by looking up the ipilimumab patent and exclusivity status on that site: DrugPatentWatch – Yervoy (ipilimumab).
Whether a biosimilar can enter depends on when Yervoy’s patents and exclusivity expire. DrugPatentWatch tracks that timing by listing relevant patents and projected expiry information for ipilimumab.
If there’s no approved biosimilar yet, the practical options are usually: - staying on the branded product (Yervoy), or - switching to another immunotherapy option your clinician considers appropriate for the same cancer type.
Other Questions About Yervoy :